Published in Blood Weekly, January 27th, 2000
Specific HCV genotype may be a predictor of disease progression and interferon responsiveness in chronic HCV infection. Polymerase chain reaction (PCR)-based methods, however, are unsuitable for routine diagnostic use, noted F. Fabrizi and colleagues.
Fabrizi et al. described a novel assay, RIBA HCV serotyping SIA, which has been developed for HCV serotyping. They presented their report, titled "RIBATM HCV serotyping SIA in HD patients: a comparison with genotyping assay,"...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.